Y Innovations
Venture capitalCambridge · Seed–Series B · 1 people tracked
Find your way into Y Innovations
Sign up to find every way you can get introduced to Y Innovations
- Your email: who you already know at Y Innovations, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Y Innovations team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Y Innovations Group operates at the intersection of science, capital, strategy, and transaction execution across artificial intelligence, biotechnology/life sciences, and energy. Its venture capital arm, Yung Ventures, pursues high-conviction, thesis-driven investments in life sciences and the energy transition, pairing the technical depth of subject-matter experts with the operating experience of industry veterans to back companies at stages where that combination matters most. The broader group supplements investing with full life-cycle advisory services spanning corporate strategy, intellectual property, market and competitive intelligence, investment diligence, business development, and regulatory readiness.
Source: firm website, verified Oct 2, 2026.
Team · 1 people
from public directoriesWhat they invest in
from 2 of 2 portfolio companiesAI & Machine Learning ×1Biotech ×1Deep Tech ×1Enterprise Software ×1Future of Work ×1Healthtech ×1SaaS ×1
HQs:United States×1
Investments · 2 tracked
founders shown can be your intro pathCalendly is a scheduling platform that integrates with Microsoft Teams to automatically generate and include Teams video conferencing links in calendar events.
Enterprise SoftwareFuture of WorkSaaS
Tope Awotona(Founder, Chief Executive Officer)in
Co-investorsAlumni VenturesAtlanta Tech VillageBasecamp FundCoatue ManagementCVX VenturesFirst Row Partners+18 more
ParcelBio develops APEXm, a proprietary mRNA platform that enhances protein expression for longer-lasting therapeutic effect compared to conventional mRNA technologies.
AI & Machine LearningBiotechDeep TechHealthtechSan Francisco, US
David Weinberg(Founder)inChris Carlson(Founder)in
BoardMorgan Cheatham(Director)in
Co-investorsY CombinatorBreyer CapitalGeneral CatalystAlumni VenturesLexi VenturesMetaplanet+12 more
Portfolio news
latest coverage across their companiesParcelBio · finsmes.com · May 7, 2026
Frequently asked questions
- What stage does Y Innovations invest at?
- Y Innovations invests at the Seed, Series A, Series B stages.
- What sectors does Y Innovations focus on?
- Y Innovations focuses on AI & Machine Learning, Biotech, Cleantech, Energy, Healthtech.
- Where is Y Innovations located?
- Y Innovations is headquartered in Cambridge, US.
- Who does Y Innovations co-invest with?
- Y Innovations most often shares deals with Coatue Management, Gener8tor, Hustle Fund, among 22 tracked co-investors.
Similar investors
Blume Ventures is a seed and pre-Series A investment firm headquartered in Mumbai that focuses on early-stage companies in India.
Tech Council Ventures helps entrepreneurs build successful companies by connecting them with innovative firms and experts, and fostering community. It is associated with TechUnited:NJ, a New Jersey innovation and entrepreneurship organization.
Blindspot Ventures is an infrastructure-focused technology investment fund that backs founders building foundational platforms, systems, and technologies for critical industries.
Obvious is a venture capital firm focused on supporting founders building solutions to humanity's largest challenges across planetary health, human health, and economic health.
EMV Capital is a deep tech and life sciences venture capital investment group that invests in, strengthens, and manages early-stage companies with attractive intellectual property. It uses a capital-efficient model combining syndicated investments, balance sheet stakes, and fund deployment.










.png)



